CLINICAL TRIALS PROFILE FOR PIQRAY
✉ Email this page to a colleague
All Clinical Trials for PIQRAY
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02379247 ↗ | BYL719 and Nab-Paclitaxel in Locally Recurrent or Metastatic HER-2 Negative Breast Cancer | Active, not recruiting | Novartis Pharmaceuticals | Phase 1/Phase 2 | 2015-02-01 | Investigate the use of BYL719 (alpelisib) as combination therapy with Nab-Paclitaxel in locally recurrent or metastatic HER-2 negative breast cancer. |
NCT02379247 ↗ | BYL719 and Nab-Paclitaxel in Locally Recurrent or Metastatic HER-2 Negative Breast Cancer | Active, not recruiting | Priyanka Sharma | Phase 1/Phase 2 | 2015-02-01 | Investigate the use of BYL719 (alpelisib) as combination therapy with Nab-Paclitaxel in locally recurrent or metastatic HER-2 negative breast cancer. |
NCT02379247 ↗ | BYL719 and Nab-Paclitaxel in Locally Recurrent or Metastatic HER-2 Negative Breast Cancer | Active, not recruiting | University of Kansas Medical Center | Phase 1/Phase 2 | 2015-02-01 | Investigate the use of BYL719 (alpelisib) as combination therapy with Nab-Paclitaxel in locally recurrent or metastatic HER-2 negative breast cancer. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for PIQRAY
Condition Name
Clinical Trial Locations for PIQRAY
Trials by Country
Clinical Trial Progress for PIQRAY
Clinical Trial Phase
Clinical Trial Sponsors for PIQRAY
Sponsor Name